AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
LONDON, GREATER LONDON, UK, August 27, 2024 /EINPresswire.com/ -- The global deep vein thrombosis (DVT) market has demonstrated steady growth, expanding from $1.03 billion in 2023 to $1.07 billion in 2024, reflecting a compound annual growth rate (CAGR) of 4.5%. Despite challenges, such as varying medical guidelines and the impact of rising obesity rates, the market is set to reach $1.26 billion by 2028at a compound annual growth rate (CAGR) of 4.1%, driven by an aging population, increasing prevalence of lifestyle diseases, and advancements in patient-centric care.
Rising Prevalence of Obesity Drives Market Growth
The increasing prevalence of obesity is a significant driver of the deep vein thrombosis market. Obesity, characterized by excessive body fat, heightens the risk of venous thromboembolism (VTE), including DVT and pulmonary embolism (PE). According to the World Heart Federation, around 2.3 billion people globally are obese or overweight, with projections indicating this number could reach 2.7 billion by 2025. This growing obesity trend underscores the need for effective DVT management solutions.
Explore comprehensive insights into the global deep vein thrombosis market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=10616&type=smp
Major Players and Market Trends
Key companies in the deep vein thrombosis market include Abbott Laboratories, Bristol-Myers Squibb Company, Sanofi-Aventis U.S. LLC, Daiichi Sankyo Company Limited, and many others. These players are focusing on product innovation, with notable developments such as Penumbra Inc.'s Lightning Flash thrombectomy system, launched in January 2023. This advanced system features novel technologies for efficient clot removal and improved safety profiles.
Trends Shaping the Market
Significant trends in the deep vein thrombosis market include increased risk factors awareness, advancements in diagnostic techniques, and innovative treatment therapies. Public health initiatives and emphasis on preventive care are also shaping the market, driving the development of new solutions for DVT management.
Segments:
• By Drug Class: Anticoagulants, Inferior Vena Cava Filters, Other Drug Class
• By Treatment: Surgery, Drugs, Other Treatments
• By Mode Of Administration: Injectable, Oral, Other Modes Of Action
• By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
• By End User: Hospitals, Homecare, Specialty Clinics, Other End-users
Geographical Insights: North America Leading the Market
North America was the largest market for deep vein thrombosis in 2023. However, Asia-Pacific is expected to be the fastest-growing region during the forecast period, driven by rising healthcare investments and growing awareness of DVT management in the region.
Explore the report store to make a direct purchase of the report
https://www.thebusinessresearchcompany.com/report/deep-vein-thrombosis-global-market-report
Deep Vein Thrombosis Global Market Report 2024from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries:Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
TheDeep Vein Thrombosis Global Market Report 2024byThe Business Research Company is the most comprehensive report that provides insights on deep vein thrombosis market size, deep vein thrombosis market drivers and trends, deep vein thrombosis market major players, competitors' revenues, market positioning, and market growth across geographies.The deep vein thrombosis market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Blood Collection Devices Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-collection-devices-global-market-report
Vein Illuminator Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/vein-illuminator-global-market-report
Anemia And Other Blood Disorder Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/anemia-and-other-blood-disorder-drugs-global-market-report
About The Business Research Company ?
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
[email protected]
Visit us on social media:
Facebook
X
LinkedIn
Legal Disclaimer:
EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.
